Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 3,247,005 | 2,976,965 | 4,133,304 | 18,238,450 | 22,451,330 |
| Cost of Goods | 726,133 | 585,741 | 649,164 | 3,155,532 | 3,444,596 |
| Gross Profit | 2,520,872 | 2,391,225 | 3,484,140 | 15,082,920 | 19,006,740 |
| Operating Expenses | 4,110,509 | 3,814,169 | 2,737,084 | 1,763,099 | 925,070 |
| Operating Income | -1,589,504 | -1,422,204 | 747,220 | 13,320,350 | 18,082,260 |
| Interest Expense | 78,972 | 29,650 | 25,867 | 19,913 | 360,964 |
| Other Income | 479,601 | 718,514 | 562,363 | 348,003 | 80,104 |
| Pre-tax Income | -1,188,875 | -733,339 | 1,283,716 | 13,648,440 | 17,801,400 |
| Income Tax | 96,508 | -13,418 | 276,852 | 3,708,356 | 5,624,339 |
| Net Income Continuous | -1,285,384 | -719,921 | 1,006,864 | 9,940,084 | 12,177,060 |
| Net Income | $-1,285,384 | $-719,921 | $1,006,864 | $9,940,084 | $12,177,060 |
| EPS Basic Total Ops | -5.32 | -3.00 | 4.19 | 40.86 | 49.90 |
| EPS Basic Continuous Ops | -5.32 | -2.99 | 4.18 | 40.86 | 49.91 |
| EPS Diluted Total Ops | -5.32 | -3.00 | 4.15 | 39.79 | 46.89 |
| EPS Diluted Continuous Ops | -5.32 | -2.99 | 4.15 | 39.79 | 46.89 |
| EPS Diluted Before Non-Recurring Items | N/A | -3.00 | 4.15 | 39.80 | 46.89 |
| EBITDA(a) | $-1,156,404 | $-1,099,738 | $945,714 | $13,450,260 | $18,171,230 |